Ferumoxytol 510 mg/17mL

Ferumoxytol 510 mg/17mL is an intravenous iron supplement designed to treat iron deficiency anemia. This single-dose injection is manufactured by Sandoz Inc. and is suitable for patients who cannot tolerate oral iron therapy.

Ferumoxytol is primarily used to address iron deficiency anemia in patients who require intravenous iron therapy. It is often recommended for individuals who cannot absorb iron effectively through oral supplements or who need rapid iron replenishment. This medication is particularly useful for those with chronic kidney disease or other conditions that hinder iron absorption.

Ferumoxytol works by providing a concentrated source of iron directly into the bloodstream, which helps to replenish iron stores and support the production of red blood cells. Patients may experience improved energy levels and reduced symptoms of anemia over time. However, some individuals may experience temporary side effects such as flushing, dizziness, or injection site reactions.

Ferumoxytol should be administered under the supervision of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before receiving this injection. Patients with a history of allergic reactions to iron supplements or any components of Ferumoxytol should use this medication with caution.

Ferumoxytol may interact with certain medications, including other iron supplements and drugs that affect iron metabolism. It is advisable to discuss all current medications with a healthcare provider before starting Ferumoxytol therapy. Additionally, patients should avoid taking oral iron supplements simultaneously with Ferumoxytol unless directed by a healthcare professional.